Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Bioactive compounds from marine foods : plant and animal sources / / edited by Blanca Hernández-Ledesma and Miguel Herrero
| Bioactive compounds from marine foods : plant and animal sources / / edited by Blanca Hernández-Ledesma and Miguel Herrero |
| Autore | Hernández-Ledesma Blanca |
| Pubbl/distr/stampa | Chichester, West Sussex : , : John Wiley & Sons Inc., , 2014 |
| Descrizione fisica | 1 online resource (467 p.) |
| Disciplina | 615.3/21 |
| Altri autori (Persone) |
Hernandez-LedesmaBlanca
HerreroMiguel |
| Collana | IFT Press series |
| Soggetto topico |
Pharmacognosy
Marine pharmacology Materia medica, Vegetable Natural products - Therapeutic use Bioactive compounds |
| ISBN |
1-118-41287-7
1-118-41289-3 1-118-41286-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Bioactive Compounds from Marine Foods; Contents; List of Contributors; 1 An Update on the Biomedical Prospects of Marine-derived Small Molecules with Fascinating Atom and Stereochemical Diversity; 1.1 Introduction; 1.1.1 Overview of known compounds, highlighting molecules of significance; 1.1.1.1 Clinical candidates and MDSM chemical probes; 1.1.2 Selected important marine sources of MDSMs; 1.1.2.1 Macroorganisms: an analysis of their critical role; 1.1.2.2 Microorganisms: questions about their being the actual source; 1.1.3 Highlights of MDSMs of therapeutic potential; 1.1.3.1 Terpene
1.1.3.2 Polyketide1.1.3.3 Alkaloid; 1.1.3.4 Depsipeptide; 1.1.3.5 Polyketide-peptide; 1.1.4 New insights and lessons that address supply challenges; 1.2 A view based on atom diversity; 1.2.1 Terpene; 1.2.2 Polyketide; 1.2.3 Alkaloid; 1.2.4 Depsipeptide; 1.2.5 Polyketide-peptide; 1.3 A view based on stereochemical diversity; 1.3.1 Terpene; 1.3.2 Polyketide; 1.3.3 Alkaloid; 1.3.4 Depsipeptide; 1.3.5 Polyketide-peptide; 1.4 Case studies of chemical probes and chemical probes in the therapeutic discovery pipeline; 1.5 Conclusion; Acknowledgments; References 2 Antihypertensive Peptides from Marine Sources2.1 Introduction; 2.2 Marine antihypertensive peptides and blood pressure control; 2.3 Generation of marine antihypertensive peptides; 2.4 Structure-activity relationships; 2.5 Bioavailability; 2.6 In vivo animal studies; 2.7 In vivo human studies; 2.8 Marine peptides as antihypertensive ingredients; 2.9 Conclusion; Acknowledgments; References; 3 Bioactive Peptides from Marine Processing Byproducts; 3.1 Introduction; 3.2 Fish muscle proteins: precursors of fish bioactive peptides; 3.3 Fish meal production; 3.4 Fish silage production 3.5 Traditional fermented fish protein products3.6 Strategies for the generation of bioactive peptides from marine byproducts; 3.6.1 Marine-derived peptides and human health; 3.6.1.1 Marine-derived peptides in the physiological control and maintenance of blood pressure: renin and ACE-I; 3.6.1.2 Antimicrobial peptides from marine sources and byproducts; 3.6.1.3 Antioxidant peptides from marine byproducts; 3.6.2 Membrane processing and the future for marine-derived bioactive peptide products; 3.7 Conclusion; Acknowledgments; References; 4 Development of Marine Peptides as Anticancer Agents 4.1 Introduction4.2 Peptides that induce apoptosis; 4.2.1 Peptides that activate the intrinsic mitochondrial pathway; 4.2.2 Peptides that target the JNK or p38 MAPK pathways; 4.2.3 Marine peptides that target the PI3K/AKT pathway; 4.2.4 Peptides without a known mechanism for their apoptosis-inducing activity; 4.3 Peptides that affect the tubulin-microtubule equilibrium; 4.4 Peptides that inhibit angiogenesis; 4.5 Peptides without a known mechanism for their antitumor activity; 4.6 Conclusion; Acknowledgments; References; 5 Using Marine Cryptides against Metabolic Syndrome 5.1 Marine cryptides |
| Record Nr. | UNINA-9910139000103321 |
Hernández-Ledesma Blanca
|
||
| Chichester, West Sussex : , : John Wiley & Sons Inc., , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive compounds from marine foods : plant and animal sources / / edited by Blanca Hernández-Ledesma and Miguel Herrero
| Bioactive compounds from marine foods : plant and animal sources / / edited by Blanca Hernández-Ledesma and Miguel Herrero |
| Autore | Hernández-Ledesma Blanca |
| Pubbl/distr/stampa | Chichester, West Sussex : , : John Wiley & Sons Inc., , 2014 |
| Descrizione fisica | 1 online resource (467 p.) |
| Disciplina | 615.3/21 |
| Altri autori (Persone) |
Hernandez-LedesmaBlanca
HerreroMiguel |
| Collana | IFT Press series |
| Soggetto topico |
Pharmacognosy
Marine pharmacology Materia medica, Vegetable Natural products - Therapeutic use Bioactive compounds |
| ISBN |
1-118-41287-7
1-118-41289-3 1-118-41286-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Bioactive Compounds from Marine Foods; Contents; List of Contributors; 1 An Update on the Biomedical Prospects of Marine-derived Small Molecules with Fascinating Atom and Stereochemical Diversity; 1.1 Introduction; 1.1.1 Overview of known compounds, highlighting molecules of significance; 1.1.1.1 Clinical candidates and MDSM chemical probes; 1.1.2 Selected important marine sources of MDSMs; 1.1.2.1 Macroorganisms: an analysis of their critical role; 1.1.2.2 Microorganisms: questions about their being the actual source; 1.1.3 Highlights of MDSMs of therapeutic potential; 1.1.3.1 Terpene
1.1.3.2 Polyketide1.1.3.3 Alkaloid; 1.1.3.4 Depsipeptide; 1.1.3.5 Polyketide-peptide; 1.1.4 New insights and lessons that address supply challenges; 1.2 A view based on atom diversity; 1.2.1 Terpene; 1.2.2 Polyketide; 1.2.3 Alkaloid; 1.2.4 Depsipeptide; 1.2.5 Polyketide-peptide; 1.3 A view based on stereochemical diversity; 1.3.1 Terpene; 1.3.2 Polyketide; 1.3.3 Alkaloid; 1.3.4 Depsipeptide; 1.3.5 Polyketide-peptide; 1.4 Case studies of chemical probes and chemical probes in the therapeutic discovery pipeline; 1.5 Conclusion; Acknowledgments; References 2 Antihypertensive Peptides from Marine Sources2.1 Introduction; 2.2 Marine antihypertensive peptides and blood pressure control; 2.3 Generation of marine antihypertensive peptides; 2.4 Structure-activity relationships; 2.5 Bioavailability; 2.6 In vivo animal studies; 2.7 In vivo human studies; 2.8 Marine peptides as antihypertensive ingredients; 2.9 Conclusion; Acknowledgments; References; 3 Bioactive Peptides from Marine Processing Byproducts; 3.1 Introduction; 3.2 Fish muscle proteins: precursors of fish bioactive peptides; 3.3 Fish meal production; 3.4 Fish silage production 3.5 Traditional fermented fish protein products3.6 Strategies for the generation of bioactive peptides from marine byproducts; 3.6.1 Marine-derived peptides and human health; 3.6.1.1 Marine-derived peptides in the physiological control and maintenance of blood pressure: renin and ACE-I; 3.6.1.2 Antimicrobial peptides from marine sources and byproducts; 3.6.1.3 Antioxidant peptides from marine byproducts; 3.6.2 Membrane processing and the future for marine-derived bioactive peptide products; 3.7 Conclusion; Acknowledgments; References; 4 Development of Marine Peptides as Anticancer Agents 4.1 Introduction4.2 Peptides that induce apoptosis; 4.2.1 Peptides that activate the intrinsic mitochondrial pathway; 4.2.2 Peptides that target the JNK or p38 MAPK pathways; 4.2.3 Marine peptides that target the PI3K/AKT pathway; 4.2.4 Peptides without a known mechanism for their apoptosis-inducing activity; 4.3 Peptides that affect the tubulin-microtubule equilibrium; 4.4 Peptides that inhibit angiogenesis; 4.5 Peptides without a known mechanism for their antitumor activity; 4.6 Conclusion; Acknowledgments; References; 5 Using Marine Cryptides against Metabolic Syndrome 5.1 Marine cryptides |
| Record Nr. | UNINA-9910819805403321 |
|
Hernández-Ledesma Blanca
|
||
| Chichester, West Sussex : , : John Wiley & Sons Inc., , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Peptides for Health Benefits 2019 : Volume 1
| Peptides for Health Benefits 2019 : Volume 1 |
| Autore | Hernández-Ledesma Blanca |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (340 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
ACE-inhibitory activity
acrylamide airway inflammation alcalase hydrolysate Alzheimer's disease AMD AMP identification and design amyloid amyloid fibrils and endothelial regeneration angiogenic precursor cells angiotensin I converting enzyme anti-biofilm peptides anti-inflammatory antibiotic resistance antifungal activity antigen-specific antihypertensive peptides antimicrobial peptide antimicrobial peptides antimicrobial peptides (AMPs) antimicrobial resistance antioxidant activity antioxidant peptide antiproliferative assay antisepsis, peptide antibiotics apolipoprotein E arthritis asthma Aβ peptide bioactive peptide bioactive peptides biomarkers BIOPEP-UWM database biosynthesis bone erosion cancer antigen cancer stem cells cartilage destruction cathelicidins Cec-analogs Cecropins central nervous system diseases chemoprevention Chlorella sorokiniana chronic diseases Clostridioides difficile CNV collagen collagen peptide colorectal cancer combinatorial library confocal microscopy conjugation copper Crassostrea angulata cryptides CXCR3 cystic fibrosis cytoprotective effect database defensins diseases docetaxel doxorubicin dry-cured pork ham dyslipidemia endothelial dysfunction endothelial progenitor cells energy expenditure enteric nervous system enzyme extra domain B fermentation fetal bovine serum (FBS) fibroblasts fibronectin Fmoc/tBu food intake regulation food-derived foods formyl peptide receptors FPYLRH fresh tissue functional food galanin gender differences glioma GPR10 Histatin-5 host defense peptides Hs02 human antimicrobial peptides human keratinocytes humanized mouse hybrid peptide hydrolysis hydroxyprolyl-glycine (Hyp-Gly) hyperglycemia hypertension immune checkpoint inhibitor immune response immune suppression immunomodulant in silico In situ tetramer staining inflammation inflammatory bowel disease insects intragenic antimicrobial peptide Lactoferricin B (Lfcin B) library design ligands lunasin MDA MDR infectious diseases membrane activity MHC tetramer migration miiuy croaker (Miichthys miiuy) mode of action molecular blind docking molecular docking molecular weight monocyte MRSA multimeric peptides mutagenesis n/a nano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS) neuroprotection neurotensin NF-κB non-atopic asthma nutraceuticals nutrition obesity oral delivery osteostatin oxidative stress pegylated glucagon-like peptide 1 peptide peptide vaccine peptide-drug conjugate physico-chemical properties PI3K/Akt pathway pidotimod pig piscidins platelets polymicrobial biofilms pro-inflammatory pro-inflammatory cytokines prolactin-releasing peptide prolyl-hydroxyproline (Pro-Hyp) prostate cancer protection ability proteolysis proteome microarray proteomics pseudin-2 Pseudomonas aeruginosa pulmonary emphysema RF-amide peptides rheumatic diseases screening sheepskin signaling Sjögren's syndrome SMILES code solid-phase synthesis sPLA2 Staphylococcus aureus stomach swim bladder synergistic effects synergy T cell T cells targeting temporin therapeutic potential type 1 diabetes vasoactive intestinal peptide VEGFR1 velvet antler VPAC1 receptor VPAC2 receptor whey peptides Αβ oligomer |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Peptides for Health Benefits 2019 |
| Record Nr. | UNINA-9910557631703321 |
|
Hernández-Ledesma Blanca
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Peptides for Health Benefits 2019 : Volume 2
| Peptides for Health Benefits 2019 : Volume 2 |
| Autore | Hernández-Ledesma Blanca |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (342 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
ACE-inhibitory activity
acrylamide airway inflammation alcalase hydrolysate Alzheimer's disease AMD AMP identification and design amyloid amyloid fibrils and endothelial regeneration angiogenic precursor cells angiotensin I converting enzyme anti-biofilm peptides anti-inflammatory antibiotic resistance antifungal activity antigen-specific antihypertensive peptides antimicrobial peptide antimicrobial peptides antimicrobial peptides (AMPs) antimicrobial resistance antioxidant activity antioxidant peptide antiproliferative assay antisepsis, peptide antibiotics apolipoprotein E arthritis asthma Aβ peptide bioactive peptide bioactive peptides biomarkers BIOPEP-UWM database biosynthesis bone erosion cancer antigen cancer stem cells cartilage destruction cathelicidins Cec-analogs Cecropins central nervous system diseases chemoprevention Chlorella sorokiniana chronic diseases Clostridioides difficile CNV collagen collagen peptide colorectal cancer combinatorial library confocal microscopy conjugation copper Crassostrea angulata cryptides CXCR3 cystic fibrosis cytoprotective effect database defensins diseases docetaxel doxorubicin dry-cured pork ham dyslipidemia endothelial dysfunction endothelial progenitor cells energy expenditure enteric nervous system enzyme extra domain B fermentation fetal bovine serum (FBS) fibroblasts fibronectin Fmoc/tBu food intake regulation food-derived foods formyl peptide receptors FPYLRH fresh tissue functional food galanin gender differences glioma GPR10 Histatin-5 host defense peptides Hs02 human antimicrobial peptides human keratinocytes humanized mouse hybrid peptide hydrolysis hydroxyprolyl-glycine (Hyp-Gly) hyperglycemia hypertension immune checkpoint inhibitor immune response immune suppression immunomodulant in silico In situ tetramer staining inflammation inflammatory bowel disease insects intragenic antimicrobial peptide Lactoferricin B (Lfcin B) library design ligands lunasin MDA MDR infectious diseases membrane activity MHC tetramer migration miiuy croaker (Miichthys miiuy) mode of action molecular blind docking molecular docking molecular weight monocyte MRSA multimeric peptides mutagenesis n/a nano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS) neuroprotection neurotensin NF-κB non-atopic asthma nutraceuticals nutrition obesity oral delivery osteostatin oxidative stress pegylated glucagon-like peptide 1 peptide peptide vaccine peptide-drug conjugate physico-chemical properties PI3K/Akt pathway pidotimod pig piscidins platelets polymicrobial biofilms pro-inflammatory pro-inflammatory cytokines prolactin-releasing peptide prolyl-hydroxyproline (Pro-Hyp) prostate cancer protection ability proteolysis proteome microarray proteomics pseudin-2 Pseudomonas aeruginosa pulmonary emphysema RF-amide peptides rheumatic diseases screening sheepskin signaling Sjögren's syndrome SMILES code solid-phase synthesis sPLA2 Staphylococcus aureus stomach swim bladder synergistic effects synergy T cell T cells targeting temporin therapeutic potential type 1 diabetes vasoactive intestinal peptide VEGFR1 velvet antler VPAC1 receptor VPAC2 receptor whey peptides Αβ oligomer |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Peptides for Health Benefits 2019 |
| Record Nr. | UNINA-9910557492903321 |
|
Hernández-Ledesma Blanca
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||